SCHEMBL5455211

SCHEMBL5455211

O=C1/C(=C\c2ccc(O)c(O)c2)SC(=S)N1c1ccc(O)c(O)c1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPD1 P10809 1/20 0.85
HSPE1 P61604 1/20 0.85
DUSP26 Q9BV47 1/20 0.73
DUSP22 Q9NRW4 4/20 0.63
DUSP3 P51452 1/20 0.63
HSD17B3 P37058 2/20 0.61
CFTR P13569 4/20 0.59
MEN1 O00255 5/20 0.58
KMT2A Q03164 5/20 0.58
GAA P10253 3/20 0.58
POLB P06746 3/20 0.58
NSD2 O96028 2/20 0.58
HSP90AA1 P07900 1/20 0.58
CASP3 P42574 1/20 0.58
SENP8 Q96LD8 1/20 0.58
SENP7 Q9BQF6 1/20 0.58
SENP6 Q9GZR1 1/20 0.58
KDM4E B2RXH2 1/20 0.58
JAK2 O60674 1/20 0.58
ALDH1A1 P00352 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5455212 1.00 HSPD1 (0.85) HSPD1HSPE1DUSP26DUSP22DUSP3
SCHEMBL2403963 0.90 HSPD1 (0.81) HSPD1HSPE1DUSP26DUSP22DUSP3
SCHEMBL2403960 0.90 HSPD1 (0.81) HSPD1HSPE1DUSP26DUSP22DUSP3
SCHEMBL2403957 0.90 HSPD1 (0.81) HSPD1HSPE1DUSP26DUSP22DUSP3
SCHEMBL14788063 0.89 HSPD1 (0.76) HSPD1HSPE1DUSP26DUSP22DUSP3
SCHEMBL5461744 0.87 HSPD1 (0.70) HSPD1HSPE1DUSP26DUSP22HSD17B3
SCHEMBL5461746 0.87 HSPD1 (0.70) HSPD1HSPE1DUSP26DUSP22HSD17B3
SCHEMBL12671881 0.87 CFTR (0.79) HSPD1HSPE1DUSP26DUSP22HSD17B3
SCHEMBL2489942 0.87 DUSP26 (0.73) HSPD1HSPE1DUSP26DUSP22CFTR
SCHEMBL14788077 0.87 DUSP26 (0.73) HSPD1HSPE1DUSP26DUSP22CFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070276011-A1 Plasminogen Activator Inhibitor-1 Inhibitor INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC. (JP) 2007-11-29 US disclosed
EP-1666469-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR Institute of Medicinal Molecular Design, Inc. (JP) 2006-06-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070276011-A1 Plasminogen Activator Inhibitor-1 Inhibitor SERPINE1, SERPINC1, SERPINB1 HSPD1 2213/4885HSPE1 1812/4885DUSP26 4769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.